Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR Jr, Minsky BD, Ludmir EB.
Pasalic D, et al. Among authors: grossberg aj.
Eur J Cancer. 2020 Sep;136:176-185. doi: 10.1016/j.ejca.2020.06.015. Epub 2020 Jul 20.
Eur J Cancer. 2020.
PMID: 32702645
Free PMC article.
Review.